Search research articles
Contact Us
Filters
Showing results (11-20 of 215) with videos related to
Page
of 22
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 12, 2011
Treatment of acute promyelocytic leukemia for older patients
Thomas Prebet, Steven D Gore
Blood
|
March 2, 2013
Demethylation demystification
Lauren Suarez, Steven D Gore
Epigenomics
|
November 30, 2011
Epigenetic targets in human neoplasms
Tamer E Fandy, Steven D Gore
Leukemia Research
|
December 14, 2002
Commentary: topoisomerases as targets in acute leukemia: I, II, I plus II or none?
Sami N Malek, Steven D Gore
Seminars in Hematology
|
July 15, 2005
Future directions for the use of hypomethylating agents
Guillermo Garcia-Manero, Steven D Gore
Leukemia & Lymphoma
|
April 10, 2008
DNA methyltransferase inhibitors: class effect or unique agents?
Elizabeth A Griffiths, Steven D Gore
Expert Review of Hematology
|
October 8, 2013
Should elderly patients with higher-risk myelodysplastic syndromes undergo allogeneic hematopoietic stem cell transplantation?
Amer M Zeidan, Steven D Gore
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2007
Addition of histone deacetylase inhibitors in combination therapy
Hetty E Carraway, Steven D Gore
Blood
|
June 23, 2009
MicroRNA: mIR-ly regulators of DNMT?
Elizabeth A Griffiths, Steven D Gore
Advances in Experimental Medicine and Biology
|
September 8, 2012
Epigenetic therapies in MDS and AML
Elizabeth A Griffiths, Steven D Gore
Page
of 22
Search research articles
Search
Showing results (11-20 of 215) with videos related to
Sort By:
Page
of 22
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 12, 2011
Treatment of acute promyelocytic leukemia for older patients
Thomas Prebet, Steven D Gore
Blood
|
March 2, 2013
Demethylation demystification
Lauren Suarez, Steven D Gore
Epigenomics
|
November 30, 2011
Epigenetic targets in human neoplasms
Tamer E Fandy, Steven D Gore
Leukemia Research
|
December 14, 2002
Commentary: topoisomerases as targets in acute leukemia: I, II, I plus II or none?
Sami N Malek, Steven D Gore
Seminars in Hematology
|
July 15, 2005
Future directions for the use of hypomethylating agents
Guillermo Garcia-Manero, Steven D Gore
Leukemia & Lymphoma
|
April 10, 2008
DNA methyltransferase inhibitors: class effect or unique agents?
Elizabeth A Griffiths, Steven D Gore
Expert Review of Hematology
|
October 8, 2013
Should elderly patients with higher-risk myelodysplastic syndromes undergo allogeneic hematopoietic stem cell transplantation?
Amer M Zeidan, Steven D Gore
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2007
Addition of histone deacetylase inhibitors in combination therapy
Hetty E Carraway, Steven D Gore
Blood
|
June 23, 2009
MicroRNA: mIR-ly regulators of DNMT?
Elizabeth A Griffiths, Steven D Gore
Advances in Experimental Medicine and Biology
|
September 8, 2012
Epigenetic therapies in MDS and AML
Elizabeth A Griffiths, Steven D Gore
Page
of 22